Surface protein on B cell

CR2(CR21)

CD19

TAPA-1(CD81)

mIg 

Igα/ Igβ

(CD79a and CD79B)

TLR

CD40

B7(CD80/86)

ICAM-1

MHC-1 and 2 both

CD 22

TLS Online TPP Program

#Id: 10326

#Section 2: General Biology

Antibodies against 

CTLA-4

PD-L1 or PD-1

A CTLA-4-blocking antibody, ipilimumab

TLS Online TPP Program

#Id: 10327

#Section 2: General Biology

Engineering T cells contain specially engineered T cell receptors, called chimeric antigen receptors, and the modified cells are called CAR T cells

TLS Online TPP Program

#Id: 10328

#Section 2: General Biology

Engineering T Cells to Recognize Tumor Antigens

When reactivated by inhibition of the immune checkpoint, have the capacity to recognize and kill some tumors with a large burden of mutations.

TLS Online TPP Program

#Id: 10329

#Section 2: General Biology

Binding of the extracellular TCR domain to a MHC-peptide complex triggers activation of ZAP70 protein tyrosine kinases attached to the cytosolic domains of the two adjacent ζ chains. 

TLS Online TPP Program

#Id: 10330

#Section 2: General Biology

The idea behind CARs was to engineer the T-cell receptor to trigger activation of ZAP70 in response to the presence of a tumor-specific antigen rather than the MHC peptide complex. 

TLS Online TPP Program

#Id: 10331

#Section 2: General Biology